Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

Study Identifier
CMO-AP-EYE-0438
CT.gov Identifier
NCT02731911
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Pseudophakic or phakic and scheduled for a cataract operation * Macular oedema due to DME
    Exclusion Criteria:
    * Previous Ozurdex® treatment

    Protocol Summary

    This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.

    Study Locations

    Location
    Status
    Location
    Retina and Macula Specialists,Hurstville
    Hurtsville, New South Wales, Australia, 2220
    Status
    Not applicable
    Location
    Retina Associates
    Liverpool, New South Wales, Australia, 2170
    Status
    Not applicable
    Location
    Retina and Macula Specialists, Miranda
    Miranda, New South Wales, Australia, 2228
    Status
    Not applicable
    Location
    Eye Doctors Mona Vale
    Mona Vale, New South Wales, Australia, 2103
    Status
    Not applicable
    Location
    Marsden Eye Clinic
    Parramatta, New South Wales, Australia, 2150
    Status
    Not applicable
    Location
    Retina & Vitreous Centre Strathfield
    Strathfield, New South Wales, Australia, 2135
    Status
    Not applicable
    Showing {first} - {last} of {total} Results